Limits...
Age-related macular degeneration.

Querques G, Avellis FO, Querques L, Bandello F, Souied EH - Clin Ophthalmol (2011)

Bottom Line: We now understand better the biochemical and pathological pathways involved in the genesis of AMD.Treatment of exudative AMD is based on intravitreal injection of new antivascular endothelial growth factor drugs for which there does not yet exist a unique recognized strategy of administration.No therapies are actually available for atrophic AMD, despite some experimental new pharmacological approaches. strategy of administration, safety of intravitreal injection.

View Article: PubMed Central - PubMed

Affiliation: Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris-Est Créteil, Créteil, France;

ABSTRACT

Clinical question: Is there any new knowledge about the pathogenesis and treatment of age-related macular degeneration (AMD)?

Results: We now understand better the biochemical and pathological pathways involved in the genesis of AMD. Treatment of exudative AMD is based on intravitreal injection of new antivascular endothelial growth factor drugs for which there does not yet exist a unique recognized strategy of administration. No therapies are actually available for atrophic AMD, despite some experimental new pharmacological approaches.

Implementation: strategy of administration, safety of intravitreal injection.

No MeSH data available.


Related in: MedlinePlus

Main factors that may interact in the onset and development of age-related macular degeneration.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3102591&req=5

f1-opth-5-593: Main factors that may interact in the onset and development of age-related macular degeneration.

Mentions: Alterations in macular structure that occur with advancing age, retinal blood flow modification, activation of inflammation pathways, and genetics can interact in the onset and development of AMD (Figure 1).


Age-related macular degeneration.

Querques G, Avellis FO, Querques L, Bandello F, Souied EH - Clin Ophthalmol (2011)

Main factors that may interact in the onset and development of age-related macular degeneration.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3102591&req=5

f1-opth-5-593: Main factors that may interact in the onset and development of age-related macular degeneration.
Mentions: Alterations in macular structure that occur with advancing age, retinal blood flow modification, activation of inflammation pathways, and genetics can interact in the onset and development of AMD (Figure 1).

Bottom Line: We now understand better the biochemical and pathological pathways involved in the genesis of AMD.Treatment of exudative AMD is based on intravitreal injection of new antivascular endothelial growth factor drugs for which there does not yet exist a unique recognized strategy of administration.No therapies are actually available for atrophic AMD, despite some experimental new pharmacological approaches. strategy of administration, safety of intravitreal injection.

View Article: PubMed Central - PubMed

Affiliation: Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris-Est Créteil, Créteil, France;

ABSTRACT

Clinical question: Is there any new knowledge about the pathogenesis and treatment of age-related macular degeneration (AMD)?

Results: We now understand better the biochemical and pathological pathways involved in the genesis of AMD. Treatment of exudative AMD is based on intravitreal injection of new antivascular endothelial growth factor drugs for which there does not yet exist a unique recognized strategy of administration. No therapies are actually available for atrophic AMD, despite some experimental new pharmacological approaches.

Implementation: strategy of administration, safety of intravitreal injection.

No MeSH data available.


Related in: MedlinePlus